首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   187463篇
  免费   12173篇
  国内免费   764篇
耳鼻咽喉   2703篇
儿科学   5151篇
妇产科学   3637篇
基础医学   24261篇
口腔科学   3746篇
临床医学   18270篇
内科学   39772篇
皮肤病学   2965篇
神经病学   18945篇
特种医学   6662篇
外国民族医学   13篇
外科学   27659篇
综合类   2487篇
现状与发展   3篇
一般理论   208篇
预防医学   14161篇
眼科学   5240篇
药学   11983篇
中国医学   204篇
肿瘤学   12330篇
  2023年   732篇
  2022年   1275篇
  2021年   2997篇
  2020年   1815篇
  2019年   2980篇
  2018年   3502篇
  2017年   2525篇
  2016年   2955篇
  2015年   3561篇
  2014年   5288篇
  2013年   8114篇
  2012年   11750篇
  2011年   12611篇
  2010年   7061篇
  2009年   6525篇
  2008年   11879篇
  2007年   12655篇
  2006年   12138篇
  2005年   12535篇
  2004年   11944篇
  2003年   11361篇
  2002年   10936篇
  2001年   1793篇
  2000年   1419篇
  1999年   1900篇
  1998年   2409篇
  1997年   2109篇
  1996年   1776篇
  1995年   1669篇
  1994年   1503篇
  1993年   1424篇
  1992年   1231篇
  1991年   1145篇
  1990年   1034篇
  1989年   977篇
  1988年   998篇
  1987年   904篇
  1986年   995篇
  1985年   1110篇
  1984年   1341篇
  1983年   1271篇
  1982年   1716篇
  1981年   1591篇
  1980年   1486篇
  1979年   898篇
  1978年   1016篇
  1977年   882篇
  1976年   790篇
  1975年   645篇
  1974年   686篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
12.
13.
High levels of tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine, are present in the wound fluid of chronic nonhealing wounds. This leads to increased inflammation, cytokine expression, and ultimately results in impaired wound healing and tissue destruction. Etanercept is a recombinant fusion protein that consists of the soluble TNF receptor (p75) linked to the Fc portion of human IgG1. It is an effective inhibitor of TNF-alpha and has been shown to provide rapid and sustained improvement in rheumatoid arthritis by acting as a soluble receptor binding TNF-alpha and preventing its proinflammatory activities. Therefore, the aim of this study was to determine whether Etanercept could inhibit TNF-alpha activity in chronic wound fluid. Wound fluid was collected from the venous leg ulcers of 16 different patients. The effect of Etanercept on TNF-alpha activity was evaluated using both a TNF-alpha bioassay and an enzyme-linked immunoassay. Etanercept was found to reduce the cytotoxic effect of chronic wound fluid on L929 fibroblasts by approximately 30% and neutralized TNF-alpha binding in the enzyme-linked immunoassay by up to 80%. Direct application of Etanercept to chronic wounds may therefore reduce the inflammatory activity of TNF-alpha, which could reduce the chronicity of venous leg ulcers and thus aid in the healing of these wounds.  相似文献   
14.
15.
The aim of this pilot study was to examine the role of the striatum and cerebellum in the adaptation to a novel movement within a sequence of practiced movements using a motor learning paradigm. The performance of patients in the early or advanced stages of Parkinson's disease (PD) and of patients with damage to the cerebellum (CE) was compared, respectively to a group of aged and young matched controls on an adapted version of the Mirror-Tracing Test. In this task, subjects were required to trace a series of complex figures in two conditions: (1) a Practiced condition, in which the figures were composed of the juxtaposition of three simple designs that were extensively practiced before; and (2) a Mixed condition in which triads were created by replacing the last simple figure of the triads in the Practiced condition by a new simple figure that had never been traced individually before. Results showed that all clinical groups were slower than controls at tracing the Practiced triads. Most interestingly, however, only patients in the advanced stages of PD showed increased completion time to trace the triads in the Mixed condition. This suggests that a bilateral striatal dysfunction affects the ability to adapt to a novel motion within a sequence of practiced movements. Although exploratory, these results support a functional dissociation between the striatum and cerebellum in acquiring visuomotor skilled behaviors.  相似文献   
16.
17.
18.
Most attempts to tissue-engineer cartilage have involved seeding of cultured cells into a biological or synthetic scaffold. We have developed a novel two-step culture approach that makes possible the in vitro formation of cartilaginous-like tissue by mature adult bovine chondrocytes without the aid of a synthetic matrix. The first step consists of culturing chondrocytes under conditions that maintain their rounded shape and their molecular phenotype as assessed by type II collagen and aggrecan production. This step was accomplished by culturing the isolated chondrocytes in alginate beads until the cells have reestablished a proteoglycan-rich cell-associated matrix (CM). The second step consists of culturing the cells with their CM, after recovery from the beads, on a tissue culture insert with a porous membrane. In this study, young adult bovine articular chondrocytes were cultured in alginate beads in the presence of 10% or 20% fetal bovine serum (FBS). After 7 days of culture, the alginate beads were dissolved by incubating the beads for 20 min in sodium citrate buffer, a calcium chelator. Following a brief centrifugation, the cells with their CM were recovered, resuspended in medium containing 10% or 20% FBS and seeded onto a tissue culture insert. After 1 week of culture on the insert, the individual cells with their CM progressively became incorporated into a mass of cartilaginous tissue. Culture with 20% FBS resulted in the best formation of tissues. These tissues, easily recovered from the insert, were then subjected to biochemical and histological analyses. The biochemical results showed that the chondrocytes remain phenotypically stable in the tissues. The de novo tissue has a relatively high ratio of PG/collagen. Histological examination of the tissue revealed it contained a cartilage-like matrix strongly stained with toluidine blue. This scaffold-free system appears ideal to study, in vitro, the development of transplantable cartilaginous tissue.  相似文献   
19.
20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号